Role of Indoleamine 2,3-Dioxygenase in Antiviral Activity of Interferon-gamma Against Vaccinia Virus

Viral Immunol. 2005;18(4):722-9. doi: 10.1089/vim.2005.18.722.

Abstract

Interferon-gamma (IFN-gamma) has antiviral activity against poxviruses as well as many other viruses, bacteria and a parasite, Toxoplasma gondii. Inducible nitric oxide synthase (NOS2) has been shown to mediate the antiviral activity of IFN-gamma in both in vivo and in vitro experiments. In macrophages, inhibition of replication of poxviruses by IFN-gamma is NOS2-dependent. In this report we tested nonmacrophage cell lines and found that indoleamine 2,3-dioxygenase (IDO) also mediated the antiviral activity of IFN-gamma against vaccinia virus. L-tryptophan, an inhibitor of IDO, completely blocked the antiviral activity of IFN-gamma against vaccinia virus in 143B cells, an human osteosarcoma cell line, whereas N(G)-methyl-L-arginine, a NOS2 inhibitor, did not. IDO may account for the NOS2-independent antiviral mechanism induced by IFN-gamma. IFN-gamma may use different antiviral mechanisms in different cell types.

MeSH terms

  • Antiviral Agents / pharmacology
  • Blotting, Western
  • Cell Division / drug effects
  • Cell Line, Transformed
  • Cell Line, Tumor
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / genetics
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / physiology*
  • Interferon-gamma / pharmacology*
  • Nitric Oxide Synthase Type II / analysis
  • Nitric Oxide Synthase Type II / genetics
  • RNA, Messenger / analysis
  • Recombinant Proteins
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tryptophan / pharmacology
  • Vaccinia virus / drug effects
  • Vaccinia virus / growth & development*
  • Viral Plaque Assay
  • omega-N-Methylarginine / pharmacology

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • RNA, Messenger
  • Recombinant Proteins
  • omega-N-Methylarginine
  • Interferon-gamma
  • Tryptophan
  • NOS2 protein, human
  • Nitric Oxide Synthase Type II